Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4.
| Publicado en: | Breast Cancer Research Vol. 27; no. 1; pp. 1 - 18 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
7/9/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186489041&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 186489041 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 7/9/2025 vid: 27 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 186489041 10.1186/s13058-025-02086-7 186489041 ppf: 1 ppct: 17 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4. aug: au: Luo, Qing Zhang, Li Hao, Yue Xu, Chunwei Wang, Xiaojia Jia, Zhen Xie, Xiandong Huang, Zhihong Gao, Xiaomin Chen, Yu Zhu, Xue Fang, Jing Wang, Ke Yin, Yongxiang affil: https://ror.org/04mkzax54 Wuxi School of Medicine, Jiangnan University, 214122, Wuxi, Jiangsu Province, China sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|